Indication
adverse drug reactions
3 clinical trials
4 products
Clinical trial
Determination of a Trough Serum Concentration of Ofloxacin Associated to Increase in Side Effects Frequency in Elderly Treated for Bone and Joint InfectionStatus: Recruiting, Estimated PCD: 2023-06-01
Product
ofloxacinProduct
OfloxacinClinical trial
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse EventsStatus: Completed, Estimated PCD: 2023-01-01
Clinical trial
Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug ReactionsStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Product
Stimulation with EB virus